ArticleCancer cell2013

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models.

Ryan B Corcoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.